Octagon Research Solutions, Incoporated Report issue

For profit Phase 1
Founded: Berwyn PA United States (1999)
Status: Acquired by Accenture (2012)

Organization Overview

First Clinical Trial
2010
NCT01376232
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

daprodustat (Jesduvroq) (1 trial)

gemfibrozil (lopid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2